A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: Results from the PEPCAD China ISR trial

JACC: Cardiovascular Interventions

Volumn 7, Issue 2, 2014, Pages 204-211

  Xu, Bo ^a   Gao, Runlin ^a   Wang, Jian'An ^b   Yang, Yuejin ^a   Chen, Shaoliang ^c   Liu, Bin ^d   Chen, Fang ^e   Li, Zhanquan ^f   Han, Yaling ^g   Fu, Guosheng ^b   Zhao, Yelin ^a   Ge, Junbo ^h  

^a FUWAI HOSPITAL   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f Liaoning Provincial People's Hospital   (China)

^g Shenyang Northern Hospital   (China)

^h FUDAN UNIVERSITY   (China)

Author keywords

in stent restenosis; paclitaxel coated balloon(s); paclitaxel eluting stent(s)

Indexed keywords

IN-STENT RESTENOSIS; PACLITAXEL-COATED BALLOON(S); PACLITAXEL-ELUTING STENT(S);

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHINA; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; RISK FACTORS; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG ELUTING CORONARY STENT; DRUG ELUTING STENT IN STENT RESTENOSIS; FEMALE; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PACLITAXEL COATED BALLOON; PACLITAXEL ELUTING STENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STENT THROMBOSIS; TREATMENT OUTCOME;

EID: 84894347633     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.08.011     Document Type: Article

References (18)

1. B. Scheller, C. Hehrlein, and W. Bocksch et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
2. B. Scheller, C. Hehrlein, and W. Bocksch et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
3. M. Unverdorben, C. Vallbracht, and B. Cremers et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
4. J. Wöhrle, M. Zadura, and S. Möbius-Winkler et al. SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study J Am Coll Cardiol 60 2012 1733 1738
5. A. Indermuehle, R. Bahl, and A.J. Lansky et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials Heart 99 2013 327 333
6. W. Wijns, P. Kolh, N. Danchin for the Task Force on Myocardial Revascularization of the ESC and EACTS; EAPCI Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
7. B. Scheller, Y.P. Clever, and B. Kelsch et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter J Am Coll Cardiol Intv 5 2012 323 330
8. S. Habara, K. Mitsudo, and K. Kadota et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis J Am Coll Cardiol Intv 4 2011 149 154
9. H. Rittger, J. Brachmann, and A.M. Sinha et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
10. R.A. Byrne, F.J. Neumann, J. Mehilli for the ISAR-DESIRE 3 Investigators Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
11. J. Cosgrave, G. Melzi, and S. Corbett et al. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent Am Heart J 153 2007 354 359
12. F. Alfonso, M.J. Perez-Vizcayno, and J. Dutary et al. Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis: results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]) J Am Coll Cardiol Intv 5 2012 728 737
13. M. Leschke, V.T. Nhan, and M. Waliszewski et al. The "all comer" Coroflex Please drug-eluting stent registry in Europe and Asia: an overall and transcontinental assessment of the 10-month major adverse cardiac events Indian Heart J 64 2012 453 461
14. R. Mehran, G. Dangas, and A.S. Abizaid et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878
15. D.L. Walters, S.A. Harding, C.R. Walsh, P. Wong, E. Pomerantsev, and I.K. Jang Acute coronary syndrome is a common clinical presentation of in-stent restenosis Am J Cardiol 89 2002 491 494
16. M.S. Chen, J.M. John, D.P. Chew, D.S. Lee, S.G. Ellis, and D.L. Bhatt Bare metal stent restenosis is not a benign clinical entity Am Heart J 151 2006 1260 1264
17. B. Scheller, and U. Speck Potential solutions to the current problem: coated balloon EuroIntervention 4 Suppl C 2008 C63 C66
18. P. Agostoni, A. Belkacemi, M. Voskuil, H.M. Nathoe, P.A. Doevendans, and P.R. Stella Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve J Am Coll Cardiol Intv 6 2013 569 576